Regular salmeterol vs placebo
Asthma‐related non‐fatal serious adverse events ‐ adults and adolescents · patients with chronic asthma
Regular salmeterol showed no clear difference in asthma‐related non‐fatal serious adverse events ‐ adults and… compared with placebo (low certainty).
1 finding from 1 review
- Regular treatment with salmeterol for chronic asthma: serious adverse events 2008 · Cochrane Headline outcomes onlyOR 1.43 [0.75, 2.71]12 studies · 3841 participantsLow